Literature DB >> 11454694

8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells.

V Gandhi1, M Ayres, R G Halgren, N L Krett, R A Newman, S T Rosen.   

Abstract

Previous work with 8-chloro-cAMP (8-Cl-cAMP) has raised questions as to whether it works as a cAMP analogue or as a nucleoside analogue after its conversion to 8-chloro-adenosine (8-Cl-Ado). Although degradation of 8-Cl-cAMP to 8-Cl-Ado in culture medium or plasma has been shown, cellular pharmacology data are missing. The purpose of the present study was to identify the cellular metabolism of these drugs and their actions in a human multiple myeloma cell line. The cells were incubated with either 8-Cl-Ado or 8-Cl-cAMP to follow the cellular metabolism of these agents. Both 8-Cl-cAMP and 8-Cl-Ado incubation resulted in the accumulation of 8-Cl-Ado mono-, di-, and tri-phosphate (8-Cl-ATP), however, the triphosphate was the major cytotoxic metabolite. Accumulation of 8-Cl-ATP was dependent on both the exogenous concentration of 8-Cl-Ado and incubation time. At the 10 microM level of 8-Cl-Ado, >400 microM 8-Cl-ATP accumulated in multiple myeloma cells after continuous incubation for 12 h. Similar incubation with 8-Cl-cAMP also resulted in accumulation of 8-Cl-ATP in the cells, albeit at a lower level. The formation of 8-Cl-ATP from 8-Cl-cAMP was inhibited by >80% in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine in the medium, suggesting extracellular conversion of 8-Cl-cAMP to 8-Cl-Ado. Cells lacking Ado kinase did not accumulate 8-Cl-ATP, either from 8-Cl-Ado or 8-Cl-cAMP, and were resistant to these agents. There was also a decline in the endogenous level of the cellular ATP pool parallel to the accumulation of 8-C1-ATP. The elimination of 8-Cl-ATP was biphasic and slow from the cells. The accumulation of 8-Cl-ATP and a decline in the ATP pool inhibited RNA synthesis but did not affect DNA synthesis for up to 12 h of incubation. Taken together, these data demonstrate that the cytotoxic metabolite of 8-Cl-Ado and 8-Cl-cAMP is 8-Cl-ATP. Hence, 8-Cl-cAMP serves as a prodrug and is converted to 8-Cl-Ado in medium with subsequent phosphorylation to accumulate as 8-Cl-ATP in cells. At the cellular level, 8-Cl-ATP is associated with a decrease in the endogenous ATP pool; at the nuclear level, it inhibits RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454694

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro.

Authors:  Dragana Janković; Milica Pesić; Jasna Marković; Selma Kanazir; Ivanka Marković; Ljubisav Rakić; Sabera Ruzdijić
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

2.  Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP.

Authors:  Kumudha Balakrishnan; Christine M Stellrecht; Davide Genini; Mary Ayres; William G Wierda; Michael J Keating; Lorenzo M Leoni; Varsha Gandhi
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

3.  Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapy.

Authors:  Christine M Stellrecht; Lisa S Chen; Mary L Ayres; Jennifer B Dennison; Shujun Shentu; Yuling Chen; Michael J Keating; William G Wierda; Varsha Gandhi
Journal:  Br J Haematol       Date:  2017-07-24       Impact factor: 6.998

4.  Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

Authors:  Rathi N Pillai; Lisa S Chen; Mary L Ayres; Billie J Nowak; Michael W Thomas; Elizabeth J Shpall; Michael J Keating; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2012-04-23

5.  Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.

Authors:  Utthara Nayar; Jouliana Sadek; Jonathan Reichel; Denise Hernandez-Hopkins; Gunkut Akar; Peter J Barelli; Michelle A Sahai; Hufeng Zhou; Jennifer Totonchy; David Jayabalan; Ruben Niesvizky; Ilaria Guasparri; Duane Hassane; Yifang Liu; Shizuko Sei; Robert H Shoemaker; J David Warren; Olivier Elemento; Kenneth M Kaye; Ethel Cesarman
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

6.  Exposure of human lung cancer cells to 8-chloro-adenosine induces G2/M arrest and mitotic catastrophe.

Authors:  Hong-Yu Zhang; Yan-Yan Gu; Zeng-Gang Li; Yu-Hong Jia; Lan Yuan; Shu-Yan Li; Guo-Shun An; Ju-Hua Ni; Hong-Ti Jia
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

7.  8-Cl-adenosine inhibits proliferation and causes apoptosis in B-lymphocytes via protein kinase A-dependent and independent effects: implications for treatment of Carney complex-associated tumors.

Authors:  Audrey J Robinson-White; Ioannis Bossis; Hui-Pin Hsiao; Maria Nesterova; Wolfgang W Leitner; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-09-22       Impact factor: 5.958

8.  8-Amino-adenosine inhibits multiple mechanisms of transcription.

Authors:  Jennifer Ann Frey; Varsha Gandhi
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

9.  A study on the genotoxic effects of 8-Cl-cAMP on human lymphocytes in vitro.

Authors:  V Bajić; N Djelić; B Spremo-Potparević; L Zivković; Z Milićević
Journal:  Genetika       Date:  2008-05

10.  8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth.

Authors:  Elisa Stellaria Grassi; Alessandra Dicitore; Irene Negri; Maria Orietta Borghi; Giovanni Vitale; Luca Persani
Journal:  Endocrine       Date:  2016-07-27       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.